These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11128638)

  • 21. Design and synthesis of selenazole-substituted ritonavir analogs.
    Qiao J; Zhao C; Liu J; Du Y
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2379-2381. PubMed ID: 29934245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2' ligand.
    Randad RS; Lubkowska L; Eissenstat MA; Gulnik SV; Yu B; Bhat TN; Clanton DJ; House T; Stinson SF; Erickson JW
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3537-42. PubMed ID: 9934467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres.
    Rocheblave L; Bihel F; De Michelis C; Priem G; Courcambeck J; Bonnet B; Chermann JC; Kraus JL
    J Med Chem; 2002 Jul; 45(15):3321-4. PubMed ID: 12109915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.
    Jadhav PK; Ala P; Woerner FJ; Chang CH; Garber SS; Anton ED; Bacheler LT
    J Med Chem; 1997 Jan; 40(2):181-91. PubMed ID: 9003516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of triazolamers as active site inhibitors of HIV-1 protease.
    Jochim AL; Miller SE; Angelo NG; Arora PS
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6023-6. PubMed ID: 19800230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors.
    Baker CT; Salituro FG; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Schairer WC; Tung RD
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3631-6. PubMed ID: 9934484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease.
    Ma C; Nakamura N; Miyashiro H; Hattori M; Shimotohno K
    Chem Pharm Bull (Tokyo); 1999 Feb; 47(2):141-5. PubMed ID: 10071849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, asymmetric synthesis, and evaluation of pseudosymmetric sulfoximine inhibitors against HIV-1 protease.
    Lu D; Sham YY; Vince R
    Bioorg Med Chem; 2010 Mar; 18(5):2037-48. PubMed ID: 20138769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.
    Sato N; Zhang Q; Ma CM; Hattori M
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1076-80. PubMed ID: 19801861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of HIV protease inhibitors].
    Yang QG; He XC; Bai DL
    Yao Xue Xue Bao; 2005 May; 40(5):389-94. PubMed ID: 16220778
    [No Abstract]   [Full Text] [Related]  

  • 33. Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.
    Turner SR; Strohbach JW; Tommasi RA; Aristoff PA; Johnson PD; Skulnick HI; Dolak LA; Seest EP; Tomich PK; Bohanon MJ; Horng MM; Lynn JC; Chong KT; Hinshaw RR; Watenpaugh KD; Janakiraman MN; Thaisrivongs S
    J Med Chem; 1998 Aug; 41(18):3467-76. PubMed ID: 9719600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituents.
    Patel M; Rodgers JD; McHugh RJ; Johnson BL; Cordova BC; Klabe RM; Bacheler LT; Erickson-Viitanen S; Ko SS
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3217-20. PubMed ID: 10576691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
    Matsumoto H; Hamawaki T; Ota H; Kimura T; Goto T; Sano K; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1227-31. PubMed ID: 10866387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-poly(L-lysine citramide) conjugates and their in vitro anti-HIV behavior.
    Couffin-Hoarau AC; Aubertin AM; Boustta M; Schmidt S; Fehrentz JA; Martinez J; Vert M
    Biomacromolecules; 2009 Apr; 10(4):865-76. PubMed ID: 19296658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid.
    Komai T; Yagi R; Suzuki-Sunagawa H; Sakurai M; Higashida S; Sugano M; Handa H; Mohri H; Yasuoka A; Oka S; Yabe Y; Nishigaki T; Kimura S; Shimada K
    Biol Pharm Bull; 1997 Feb; 20(2):175-80. PubMed ID: 9057982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
    Tyndall JD; Reid RC; Tyssen DP; Jardine DK; Todd B; Passmore M; March DR; Pattenden LK; Bergman DA; Alewood D; Hu SH; Alewood PF; Birch CJ; Martin JL; Fairlie DP
    J Med Chem; 2000 Sep; 43(19):3495-504. PubMed ID: 11000004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationship of HIV-1 protease inhibitors containing alpha-hydroxy-beta-amino acids. Detailed study of P1 site.
    Takashiro E; Hayakawa I; Nitta T; Kasuya A; Miyamoto S; Ozawa Y; Yagi R; Yamamoto I; Shibayama T; Nakagawa A; Yabe Y
    Bioorg Med Chem; 1999 Sep; 7(9):2063-72. PubMed ID: 10530956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.
    Yu D; Sakurai Y; Chen CH; Chang FR; Huang L; Kashiwada Y; Lee KH
    J Med Chem; 2006 Sep; 49(18):5462-9. PubMed ID: 16942019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.